Showing results (11-20 of 260) with videos related to
Sort By:
Pageof 26
Clinical Pharmacokinetics|September 4, 2022
The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug-Disease Interaction Under Different Clinical ConditionsMilo Gatti, Federico PeaExpert Review of Anti-Infective Therapy|January 19, 2023
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactamsMilo Gatti, Federico PeaExpert Review of Anti-Infective Therapy|April 4, 2007
Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infectionsFederico Pea, Pierluigi VialeClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?Federico Pea, Pierluigi VialeExpert Opinion on Pharmacotherapy|March 24, 2026
Pharmacological approaches to overcome antimicrobial resistance to novel beta-lactams in MDR Gram-negative bacterial infections: Current practice and future directionsMilo Gatti, Federico PeaExpert Review of Anti-Infective Therapy|December 24, 2025
Pharmacokinetics-pharmacodynamics perspective to optimizing therapy with beta-lactams in critically ill patients: an updateMilo Gatti, Federico PeaInfectious Disease Reports|January 21, 2026
Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?Milo Gatti, Federico PeaExpert Review of Clinical Pharmacology|March 9, 2021
Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitorsMilo Gatti, Federico PeaCritical Care (London, England)|June 13, 2009
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?Federico Pea, Pierluigi VialeClinical Pharmacokinetics|March 1, 2008
Should the currently recommended twice-daily dosing still be considered the most appropriate regimen for treating MRSA ventilator-associated pneumonia with vancomycin?Federico Pea, Pierluigi VialePageof 26